339 related articles for article (PubMed ID: 25850019)
41. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
42. Cholera vaccine: new preventive tool for endemic countries.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2012 May; 8(5):682-4. PubMed ID: 22634452
[TBL] [Abstract][Full Text] [Related]
43. Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.
Kanungo S; Desai SN; Nandy RK; Bhattacharya MK; Kim DR; Sinha A; Mahapatra T; Yang JS; Lopez AL; Manna B; Bannerjee B; Ali M; Dhingra MS; Chandra AM; Clemens JD; Sur D; Wierzba TF
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003574. PubMed ID: 25764513
[TBL] [Abstract][Full Text] [Related]
44. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
Chowdhury MI; Sheikh A; Qadri F
Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
[TBL] [Abstract][Full Text] [Related]
45. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
[TBL] [Abstract][Full Text] [Related]
46. Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.
Kabir S
Clin Vaccine Immunol; 2014 Sep; 21(9):1195-205. PubMed ID: 25056361
[TBL] [Abstract][Full Text] [Related]
47. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
[TBL] [Abstract][Full Text] [Related]
48. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
49. A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines.
Philippines Cholera Committee
Bull World Health Organ; 1973; 49(4):389-94. PubMed ID: 4603994
[TBL] [Abstract][Full Text] [Related]
50. Using Mobile Health (mHealth) and geospatial mapping technology in a mass campaign for reactive oral cholera vaccination in rural Haiti.
Teng JE; Thomson DR; Lascher JS; Raymond M; Ivers LC
PLoS Negl Trop Dis; 2014; 8(7):e3050. PubMed ID: 25078790
[TBL] [Abstract][Full Text] [Related]
51. Knowledge, Attitudes, and Practices regarding Diarrhea and Cholera following an Oral Cholera Vaccination Campaign in the Solomon Islands.
Burnett E; Dalipanda T; Ogaoga D; Gaiofa J; Jilini G; Halpin A; Dietz V; Date K; Mintz E; Hyde T; Wannemuehler K; Yen C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004937. PubMed ID: 27548678
[TBL] [Abstract][Full Text] [Related]
52. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.
Schwerdtle P; Onekon CK; Recoche K
Prehosp Disaster Med; 2018 Feb; 33(1):2-6. PubMed ID: 29317005
[TBL] [Abstract][Full Text] [Related]
53. Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.
Ali M; You YA; Sur D; Kanungo S; Kim DR; Deen J; Lopez AL; Wierzba TF; Bhattacharya SK; Clemens JD
Vaccine; 2016 Jan; 34(4):479-485. PubMed ID: 26707378
[TBL] [Abstract][Full Text] [Related]
54. Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines.
Clemens JD; Stanton BF; Harris JR; Chakraborty J; Sack DA; Rao MR; Ahmed F; Ansaruzzaman M; Yunus MD; Svennerholm AM
Int J Epidemiol; 1989 Jun; 18(2):440-5. PubMed ID: 2767860
[TBL] [Abstract][Full Text] [Related]
55. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
[TBL] [Abstract][Full Text] [Related]
56. Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trial.
Najnin N; Leder K; Qadri F; Forbes A; Unicomb L; Winch PJ; Ram PK; Leontsini E; Nizame FA; Arman S; Begum F; Biswas SK; Clemens JD; Ali M; Cravioto A; Luby SP
Int J Epidemiol; 2017 Dec; 46(6):2056-2066. PubMed ID: 29025064
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.
Sur D; Kanungo S; Sah B; Manna B; Ali M; Paisley AM; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Han SH; Attridge S; Donner A; Ganguly NK; Bhattacharya SK; Nair GB; Clemens JD; Lopez AL
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1289. PubMed ID: 22028938
[TBL] [Abstract][Full Text] [Related]
58. Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.
Ali M; Nelson A; Luquero FJ; Azman AS; Debes AK; M'bang'ombe MM; Seyama L; Kachale E; Zuze K; Malichi D; Zulu F; Msyamboza KP; Kabuluzi S; Sack DA
Lancet Infect Dis; 2017 May; 17(5):538-544. PubMed ID: 28161570
[TBL] [Abstract][Full Text] [Related]
59. Use of Vibrio cholerae vaccine in an outbreak in Guinea.
Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Diallo AA; Itama C; Page AL; Quilici ML; Mengel MA; Eiros JM; Serafini M; Legros D; Grais RF
N Engl J Med; 2014 May; 370(22):2111-20. PubMed ID: 24869721
[TBL] [Abstract][Full Text] [Related]
60. Controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in Calcutta.
Das Gupta A; Sinha R; Shrivastava DL; De SP; Taneja BL; Rao MS; Abou-Gareeb AH
Bull World Health Organ; 1967; 37(3):371-85. PubMed ID: 5301381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
